-
Therapeutic Potential of Datopotamab Deruxtecan in the Treatment of Advanced Non-Small Cell Lung Cancer: Evidence to Date
23 Apr 2025 08:01 GMT
… is correlated with increased lung cancer-specific mortality in … treated non-small cell lung cancer (NSCLC) with actionable … advanced non-small cell lung cancer (NSCLC), with sequential … ± carboplatin in advanced/metastatic non-small cell lung cancer (mNSCLC …
-
J&J highlights Rybrevant-Leclaza combo’s survival benefit in EGFR-mutant lung cancer
22 Apr 2025 07:58 GMT
… EGFR-mutated non-small cell lung cancer (NSCLC) following its expanded regulatory … -line use in combination with carboplatin, pemetrexed, and Leclaza, based on …
-
Prevalence of EGFR Mutations in Vietnamese Patients with Resected Early Stage Non-Small Cell Lung Cancer: EARLY-EGFR Study
21 Apr 2025 12:39 GMT
… neoadjuvant systemic chemotherapy (carboplatin-containing combination). Targeted … and correlates of lung cancer recurrence. Clin Lung Cancer. 2020;21 … Non-Small Cell Lung Cancers in a Multiethnic … Clinicopathological Characters of Lung Cancer Patients. World J …
-
Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review
15 Apr 2025 14:11 GMT
… small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide … patients with small cell lung cancer. Lung Cancer. 2018;115:116 … with small cell lung cancer. Lung Cancer. 2020;147:237 … metastatic small cell lung cancers and patient-derived …
-
Cost-Effectiveness Analysis of Serplulimab Combined with Nab-Paclitaxel Plus Carboplatin Compared to Nab-Paclitaxel Plus Carboplatin Alone as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer in China
14 Apr 2025 14:59 GMT
… lung cancer cases and 766,898 lung cancer- … lung cancer (NSCLC) accounts for the majority (80% - 85%) of all lung cancers … nab-paclitaxel plus carboplatin chemotherapy significantly … lung cancer: a cost-effectiveness analysis. Translational Lung Cancer …
-
Bacteria-Assisted Celastrol Liposomes for Effective Chemotherapy Against Lung Cancer in Mice Model
14 Apr 2025 14:59 GMT
… of chemotherapy in treating lung cancer.4 Therefore, chemotherapeutic … metabolism in mice with lung tumors (Figure 5C). The … Fluorescence images of Lewis lung tumor-bearing mice after intravenous … the DNA-crosslinking agent carboplatin. EBioMedicine. 2019;50 …
-
Ivonescimab/Chemo Prolongs PFS in 1L Advanced Squamous NSCLC
23 Apr 2025 20:11 GMT
… non–small cell lung cancer, ultimately enhancing the … every 3 weeks, carboplatin administered via intravenous infusion … lung cancer and brain metastases. Presented at the 2024 European Lung Cancer … squamous non-small cell lung cancer. ClinicalTrials.gov. …
-
Integrated Glucocorticoids and Traditional Chinese Medicine in a Squamous Lung Cancer Patient with Dermatologic Toxicities Related to Pembrolizumab: A Case Report
09 Apr 2025 13:09 GMT
… man with advanced squamous lung cancer who developed dermatologic toxicities … response in advanced squamous lung cancer is attributed to … 500mg on day 1, carboplatin 600mg on day 1, … Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, …
-
EU approves AstraZeneca's Imfinzi─in combo with chemotherapy to treat patients with resectable non─small cell lung cancer
05 Apr 2025 07:44 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … (etoposide and either carboplatin or cisplatin) for … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond treatment …
-
First-Line Ivonescimab Plus Chemo Improves PFS in Advanced Squamous NSCLC
23 Apr 2025 15:58 GMT
… squamous non–small cell lung cancer (NSCLC), meeting the … PhD, director of Shanghai Lung Cancer, Shanghai Chest Hospital, Shanghai … cycles of chemotherapy comprising carboplatin at area under … squamous non-small cell lung cancer. ClinicalTrials.gov. Updated …
About
© 1995-2025